Technology companies such as KetteQ, Sabre, Microsoft, among others, announced their tech deals or channel partnerships.
Verkada Selects KetteQ
Verkada partnered with KetteQ to replace spreadsheet-based supply chain planning with a modern AI-enabled platform designed to improve forecasting accuracy and operational decisions. The strategy emphasizes leveraging AI to automate planning, scenario simulations, and demand forecasting. Investment in advanced supply chain technology supports scalability and responsiveness to changing market conditions. Customers benefit from improved product availability, reduced stock imbalances, and clearer planning insights. Innovation includes real-time analytics, machine learning models, and automated alerts. Growth plans focus on enhancing supply chain agility, reducing operational risks, and supporting sustained business expansion through technology-driven planning solutions.
Five Travel Technology Providers Choose Sabre Mosaic Marketplace
Five leading travel technology providers selected Sabre Mosaic Marketplace to unlock access to over forty NDC airline offers, improving digital distribution and traveler options. The strategy focuses on expanding connectivity between airlines and travel sellers using modern API technology and rich content capabilities. Investment in Sabre’s platform enables providers to offer diverse flight options, ancillary services, and personalized booking experiences. Consumers benefit from broader choice, transparent pricing, and tailored travel offers. Innovation includes real-time offer management, dynamic pricing, and seamless integrations. Growth plans emphasize scaling marketplace adoption, deepening airline partnerships, and enhancing travel retailing efficiency for global markets.
Bristol-Myers Partners with Microsoft
Bristol-Myers Squibb announced a partnership with Microsoft to develop AI-driven lung cancer detection tools that improve diagnostic accuracy and early intervention. The strategy leverages Microsoft’s AI and cloud technologies to analyze medical imaging and patient data, enabling faster and more precise identification of lung cancer markers. Investment in AI healthcare innovation aims to enhance clinical decision support and patient outcomes. Consumers benefit from earlier detection, personalized treatment insights, and improved survival prospects. Technology focus includes machine learning models, data integration, and scalable healthcare solutions. Growth plans include clinical validation, expanded adoption in medical facilities, and continued refinement of AI diagnostics.
THASNIYA VP
